Shahsafaei A - Search Results

1

Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms.

Datta MW, Shahsafaei A, Nadler LM, Freeman GJ, Dorfman DM. Datta MW, et al. Among authors: shahsafaei a. Appl Immunohistochem Mol Morphol. 2000 Sep;8(3):210-5. doi: 10.1097/00129039-200009000-00007. Appl Immunohistochem Mol Morphol. 2000. PMID: 10981873

2

Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity.

Dorfman DM, Shahsafaei A, Chan JK. Dorfman DM, et al. Among authors: shahsafaei a. Am J Surg Pathol. 1997 Aug;21(8):936-40. doi: 10.1097/00000478-199708000-00008. Am J Surg Pathol. 1997. PMID: 9255257

3

Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.

Dorfman DM, Shahsafaei A. Dorfman DM, et al. Among authors: shahsafaei a. Mod Pathol. 1997 Sep;10(9):859-63. Mod Pathol. 1997. PMID: 9310947

4

Intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) exhibits CD5 immunoreactivity: new evidence for thymic differentiation.

Dorfman DM, Shahsafaei A, Miyauchi A. Dorfman DM, et al. Among authors: shahsafaei a. Histopathology. 1998 Feb;32(2):104-9. doi: 10.1046/j.1365-2559.1998.00318.x. Histopathology. 1998. PMID: 9543665

5

Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.

Dorfman DM, Shahsafaei A, Miyauchi A. Dorfman DM, et al. Among authors: shahsafaei a. Mod Pathol. 1998 Oct;11(10):989-94. Mod Pathol. 1998. PMID: 9796728

6

BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders.

Rodig SJ, Shahsafaei A, Li B, Mackay CR, Dorfman DM. Rodig SJ, et al. Among authors: shahsafaei a. Hum Pathol. 2005 Oct;36(10):1113-9. doi: 10.1016/j.humpath.2005.08.005. Hum Pathol. 2005. PMID: 16226112

7

Patterns of expression of CD56 and CD117 on neoplastic plasma cells and association with genetically distinct subtypes of plasma cell myeloma.

Pozdnyakova O, Morgan EA, Li B, Shahsafaei A, Dorfman DM. Pozdnyakova O, et al. Among authors: shahsafaei a. Leuk Lymphoma. 2012 Oct;53(10):1905-10. doi: 10.3109/10428194.2012.676174. Epub 2012 Apr 19. Leuk Lymphoma. 2012. PMID: 22423624

8

Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases.

Shi M, Shahsafaei A, Liu C, Yu H, Dorfman DM. Shi M, et al. Among authors: shahsafaei a. Leuk Lymphoma. 2015 Jul;56(7):2087-91. doi: 10.3109/10428194.2014.968780. Epub 2014 Oct 30. Leuk Lymphoma. 2015. PMID: 25263318

9

Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas.

Tian X, Pelton A, Shahsafaei A, Dorfman DM. Tian X, et al. Among authors: shahsafaei a. Mod Pathol. 2016 Sep;29(9):1050-7. doi: 10.1038/modpathol.2016.114. Epub 2016 Jun 10. Mod Pathol. 2016. PMID: 27282353 Free article.

10

Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.

Dorfman DM, Shahsafaei A. Dorfman DM, et al. Among authors: shahsafaei a. Mod Pathol. 1996 Oct;9(10):959-65. Mod Pathol. 1996. PMID: 8902831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters